Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. At 6, the average consequence score sits below the same-window beat average of 6.4.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Children's liquid pain medication
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. At 6, the average consequence score sits below the same-window beat average of 6.4. Source depth averages 3 original sources per story, versus 2.8 across the same-window beat baseline. We currently track 1 Biotech story that mention Children's liquid pain medication, all published on March 20, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Children's liquid pain medication. Shared-story counts are live from our verified record — not editorial picks.
A major recall involving nearly 90,000 bottles of children’s liquid pain medication has been launched across North America. The recall highlights critical safety concerns regarding pediatric dosage accuracy and quality control in the over-the-counter pharmaceutical sector.
Children's liquid pain medication is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.